iCAD, Inc.
Edit

iCAD, Inc.

http://www.icadmed.com/
Last activity: 12.03.2024
Categories: AdTechContentHealthTechInformationMedTechPageServiceSkinSoftwareTechnology
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while enhancing patient care. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast, prostate and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. For more information, visit www.icadmed.com. The goal of the iCAD Facebook page is to provide useful and interesting content about our company and in support of the fight against cancer, and to foster an open and respectful dialogue relating to the specific issues and topics covered in our posts. iCAD respects the rights of individuals using social media to voice their views and opinions. However, within our social media channels, we do reserve the right to remove comments at our discretion that are considered negative, inappropriate, off-topic, abusive, misleading, factually inaccurate or commercial in nature. iCAD operates in a highly regulated industry where some comments about products may not be permissible. Public comments on the page do not reflect the views of iCAD, and the company does not endorse user-generated content. We also reserve the right to ban users from the iCAD Facebook page who exhibit these or otherwise offensive/intrusive behaviors. We ask that all individuals show respect for other members of our social media communities. IMPORTANT: The content available on this page is for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition. Only your doctor can advise you as to which treatment options are appropriate, depending on the type and stage of your condition. Your doctor must exercise his or her individual medical judgment in making treatment decisions as each patient has a unique clinical presentation and treatment needs. Reliance on any information provided herein is solely at your own risk. // TERMS AND CONDITIONS FOR UPLOADING PICTURES AND OTHER CONTENT TO THE ICAD FACEBOOK PAGE By submitting your photo to the iCAD page (including its Facebook wall) on Facebook (the “Page”), you hereby agree and consent to: iCAD and its affiliates, subsidiaries, agencies (including advertising agencies) and parents, the “Company”) using the submitted photograph(s), video(s), comment(s) and other accompanying materials (collectively, the “User Content”) for advertising, marketing, promotion and other commercial and business purposes in accordance with these terms and conditions. When you upload the User Content to the Page, you hereby grant the Company (and its licensees, advertising agencies and promotion agencies) and the employees, agencies and authorized representatives of each and all of them (collectively, “Authorized Persons”), the unrestricted, perpetual, worldwide, non-transferable, royalty-free right and license to display, exhibit, transmit, reproduce, record, digitize, modify, alter, adapt, create derivative works, exploit and otherwise use and permit others to use the User Content (including, all copyrights in the User Content) in connection with the Company’s marketing, advertising and promotion of iCAD on Facebook. By uploading User Content to the Page, you represent and warrant to the Company that: (1) you are of at least 18 years of age; (2) you own all rights in the User Content or otherwise have the right to submit the User Content to the Company; (3) the User Content does not violate or infringe upon the rights of any third party (including, any rights of copyright, trademark, publicity or privacy); (4) any persons identified in the User Content have consented to the submission of the User Content on the Page and further use of the User Content as contemplated herein; and (5) the Authorized Persons’ use of the User Content in the manner contemplated above and the rights and licenses granted hereunder do not, and will not, violate any right of, or conflict with or violate any right or commitment made to, any third party and no consent or authorization from any third party is required in connection with such use. You hereby agree to defend, indemnify and hold harmless the Authorized Persons from and against any and losses, and all claims by third parties, resulting from your breach of any of the foregoing representations or warranties. Lastly, you hereby waive, release and forever discharge the Company and each Authorized Person and each of their subsidiaries, affiliates, officers, directors, managers, members, shareholders, employees, representatives and agents from any and all rights, claims and liability relating to the use of the User Content in the manner contemplated above including, without limitation, any claims based on the invasion of privacy, commercial use of name or likeness and the right of publicity.
Likes
371
Followers
591
Followers
4.87K
Website visits
11.7K /mo.
Mentions
34
Location: United States, New Hampshire, Nashua
Employees: 51-200
Phone: +1 603-882-5200
Founded date: 1984

Investors 2

Mentions in press and media 34

DateTitleDescriptionSource
12.03.2024iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Fina...Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-year Full-Year Operating Cash...einpresswi...
04.03.2024Radiotherapy Market Trends, Size, Share, Growth, Advancement...Radiotherapy Market Radiotherapy Market to Surpass USD 9.44 Billion by 2030 Driven by Increasing Can...einpresswi...
29.11.2023RSNA23: iCAD, GE HealthCare Integrate to Advance Breast Canc...What You Should Know: – iCAD, Inc. (NASDAQ: ICAD), a provider of medical technology and innovative c...hitconsult...
14.08.2023iCAD Reports Financial Results for Second Quarter Ended June...Company to host conference call and webcast today at 4:30 PM ET NASHUA, N.H., Aug. 14, 2023 (GLOBE N...einpresswi...
27.03.2023iCAD’s Breast AI Suite Empowers Customers to Lead the Way in...iCAD, a global medical technology leader providing innovative cancer detection and therapy solutions...aithority....
27.03.2023Daily AI Roundup: Biggest Machine Learning, Robotic And Auto...This is our AI Daily Roundup . We are covering the top updates from around the world. The updates wi...aithority....
23.03.2023Why Advances in Imaging Will Revolutionize the Way We Detect...Recently, scientists shared new findings that may indicate the inner core of the earth has stopped i...medcitynew...
01.03.2023New Real-World Clinical Evidence Confirms ProFound AI Boosts...Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk eval...aithority....
08.01.2023Глубокое обучение в диагностике: как AI спасает жизни и экон...Разница между современными моделями ML и XAI. Источник: DARPA Разрабатываемые сейчас решения XAI про...vc.ru/ml/5...
06.12.2022Глубокое обучение в диагностике: как AI спасает жизни и экон...«Симптомы никогда не лгут», — так сказал самый блестящий диагност, доктор Хаус, который, увы существ...habr.com/r...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In